Pharmacological therapy in critically ill patients with peripheral and concomitant arteriopathy
Terapia farmacologica nel paziente critico con arteriopatia periferica e concomitante
DOI:
https://doi.org/10.19156/abtpn.2018.0068Keywords:
Peripheral arteriopathy, Cilostazol, Iloprost, Cardiovascular riskAbstract
Peripheral arterial disease is one of the most frequent clinical manifestations of atherosclerotic disease. The clinical picture of critical ischemia of the lower limbs is often burdened by high mortality and the risk of limb amputation. The direct and indirect prostanoids, and in particular iloprost and cilostazol, are effective in the medical treatment of peripheral arterial disease. We describe here five clinical cases in which iloprost and cilostazol have been successfully administered in arterial patients with various concomitant cardiovascular diseases, highlighting a good safety profile in relation to the cardiocascular risk profile (Cardiology).
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2018 The authors
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.